Current Neuropharmacology


Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 19 Issue: 6, June 2021

Meet Our Editorial Board Member

Volume:19   Issue: 6
Pp: 731-731
Bechan Sharma
DOI: 10.2174/1570159X1906210415123145
Published on: 15 April, 2021

In memory of Prof. Gjumrakch Aliev

Volume:19   Issue: 6
Pp: 732-732
Ferdinando Nicoletti
DOI: 10.2174/1570159X1906210415123638
Published on: 15 April, 2021

Suicidality and Cannabidiol: Opportunities and Challenges

Volume:19   Issue: 6
Pp: 733-735
Ehsan Moazen-Zadeh and Igor I. Galynker*
DOI: 10.2174/1570159X18666201015160417
Published on: 15 October, 2020

Methods for Evaluating Sensory, Affective and Cognitive Disorders in Neuropathic Rodents

Volume:19   Issue: 6
Pp: 736-746
Enza Palazzo*, Ida Marabese, Francesca Gargano, Francesca Guida, Carmela Belardo and Sabatino Maione
DOI: 10.2174/1570159X18666200831153117
Published on: 31 August, 2020

Targeting Ionotropic Glutamate Receptors in the Treatment of Epilepsy

Volume:19   Issue: 6
Pp: 747-765
Roberta Celli and Francesco Fornai *
DOI: 10.2174/1570159X18666200831154658
Published on: 31 August, 2020

A Scientometrics Analysis and Visualization of Depressive Disorder

Volume:19   Issue: 6
Pp: 766-786
Dong Xu, Yi-Lun Wang, Kun-Tang Wang, Yue Wang, Xin-Ran Dong, Jie Tang and Yuan-Lu Cui*
DOI: 10.2174/1570159X18666200905151333
Published on: 05 September, 2020

Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art

Volume:19   Issue: 6
Pp: 787-812
Leonardo Delello Di Filippo, Jonatas Lobato Duarte, Marcela Tavares Luiz, Jennifer Thayanne Cavalcante de Araújo and Marlus Chorilli *
DOI: 10.2174/1570159X18666200831160627
Published on: 31 August, 2020

Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies

Volume:19   Issue: 6
Pp: 813-831
Sheila Garcia-Rosa, Bianca de Freitas Brenha, Vinicius Felipe da Rocha, Ernesto Goulart and Bruno Henrique Silva Araujo*
DOI: 10.2174/1570159X18666200915151909
Published on: 15 September, 2020

From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer’s Disease

Volume:19   Issue: 6
Pp: 832-867
Jazmín Alarcón-Espósito*, Michael Mallea and Julio Rodríguez-Lavado*
DOI: 10.2174/1570159X18666200914155951
Published on: 14 September, 2020

Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation

Volume:19   Issue: 6
Pp: 868-884
Hai-Jian Sun, Zhi-Yuan Wu, Xiao-Wei Nie and Jin-Song Bian*
DOI: 10.2174/1570159X18666200905143550
Published on: 05 September, 2020

Inflammation Drives Alzheimer's Disease: Emphasis on 5-lipoxygenase Pathways

Volume:19   Issue: 6
Pp: 885-895
Aisha Siddiqui, Sayeed Akhtar*, Zahoor Shah, Iekhsan Othman and Yatinesh Kumari*
DOI: 10.2174/1570159X18666200924122732
Published on: 24 September, 2020